Response to Preoperative Therapy in Localized Pancreatic Cancer

Evaluation of response to preoperative therapy for patients with pancreatic adenocarcinoma has been historically difficult. Therefore, preoperative regimens have generally been selected on the basis of baseline data such as radiographic stage and serum CA 19-9 level and then typically administered f...

Full description

Bibliographic Details
Main Authors: Giampaolo Perri, Laura R. Prakash, Matthew H. G. Katz
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00516/full
_version_ 1818310546812829696
author Giampaolo Perri
Laura R. Prakash
Matthew H. G. Katz
author_facet Giampaolo Perri
Laura R. Prakash
Matthew H. G. Katz
author_sort Giampaolo Perri
collection DOAJ
description Evaluation of response to preoperative therapy for patients with pancreatic adenocarcinoma has been historically difficult. Therefore, preoperative regimens have generally been selected on the basis of baseline data such as radiographic stage and serum CA 19-9 level and then typically administered for a pre-specified duration as long as 6 months or more. The decision to proceed with resection following preoperative therapy likewise has rested upon the absence of disease progression rather than evidence for tumor response. This article reviews the basis for the evaluation of therapeutic response after preoperative therapy for pancreatic cancer in the existing scientific literature, and providing updates and new perspectives.
first_indexed 2024-12-13T07:47:47Z
format Article
id doaj.art-61239c09c3234c1bbff98fce69b2ae69
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-13T07:47:47Z
publishDate 2020-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-61239c09c3234c1bbff98fce69b2ae692022-12-21T23:54:47ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-04-011010.3389/fonc.2020.00516496882Response to Preoperative Therapy in Localized Pancreatic CancerGiampaolo PerriLaura R. PrakashMatthew H. G. KatzEvaluation of response to preoperative therapy for patients with pancreatic adenocarcinoma has been historically difficult. Therefore, preoperative regimens have generally been selected on the basis of baseline data such as radiographic stage and serum CA 19-9 level and then typically administered for a pre-specified duration as long as 6 months or more. The decision to proceed with resection following preoperative therapy likewise has rested upon the absence of disease progression rather than evidence for tumor response. This article reviews the basis for the evaluation of therapeutic response after preoperative therapy for pancreatic cancer in the existing scientific literature, and providing updates and new perspectives.https://www.frontiersin.org/article/10.3389/fonc.2020.00516/fullpancreatic cancerpreoperative therapytumor responsepathologic responseradiographic response
spellingShingle Giampaolo Perri
Laura R. Prakash
Matthew H. G. Katz
Response to Preoperative Therapy in Localized Pancreatic Cancer
Frontiers in Oncology
pancreatic cancer
preoperative therapy
tumor response
pathologic response
radiographic response
title Response to Preoperative Therapy in Localized Pancreatic Cancer
title_full Response to Preoperative Therapy in Localized Pancreatic Cancer
title_fullStr Response to Preoperative Therapy in Localized Pancreatic Cancer
title_full_unstemmed Response to Preoperative Therapy in Localized Pancreatic Cancer
title_short Response to Preoperative Therapy in Localized Pancreatic Cancer
title_sort response to preoperative therapy in localized pancreatic cancer
topic pancreatic cancer
preoperative therapy
tumor response
pathologic response
radiographic response
url https://www.frontiersin.org/article/10.3389/fonc.2020.00516/full
work_keys_str_mv AT giampaoloperri responsetopreoperativetherapyinlocalizedpancreaticcancer
AT laurarprakash responsetopreoperativetherapyinlocalizedpancreaticcancer
AT matthewhgkatz responsetopreoperativetherapyinlocalizedpancreaticcancer